GCAND.US Trafalgar International Inc

Healthcare Drug Manufacturers - Specialty & Generic USA Stocks
- USD
Market cap
-
P/E
0.1x
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is GCAND.US undervalued?

Graham number

The Graham number of Trafalgar International Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Trafalgar International Inc fundamental analysis

No fundamental analysis for Trafalgar International Inc yet.

Trafalgar International Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Trafalgar International Inc

Trafalgar International, Inc. focuses on acquiring, developing and growing businesses in the financial services, technology and intellectual property sectors. The company was formerly known as The Greater Cannabis Company, Inc. and changed its name to Trafalgar International, Inc. in July 2026. The company was founded in 2014 and is based in Miami, Florida.

Full company profile